much more likely to survive five years or longer.
"Outcome varies among lung cancer patients, even within groups that have the same stage at the time of diagnosis, and so it is difficult to know how aggressively to treat and provide follow-up care for individual patients," said the study's lead investigator, Ping Yang, M.D., Ph.D., a clinical and genetic epidemiologist at Mayo Clinic.
"In order to enhance both survival and quality of life, we are trying to establish a model that will identify patients who would benefit from additional clinical intervention, and the data we have accumulated to date could be enormously helpful," she said.
To derive these predictive factors, the researchers aim to compare 400 lung-cancer patients treated at Mayo Clinic and who have survived five or more years, with 400 patients who lived less than two years after treatment. The researchers match the groups by age at diagnosis, gender, tumor cell type, cancer stage and the number of primary lung cancers, and they examine blood samples and follow the progress of the patients' disease as well as their quality of life.
In an interim analysis of data on 150 patients in each group, the researchers specifically found that patients who experienced any progression or recurrence of their cancer were almost three times more likely to die within two years, compared to patients of the same cancer stage whose disease did not progress or return.
They also concluded that lung cancer patients who had surgery were three times as likely to have longer survival as matched patients who did not have surgery. "This can be very useful information for patients who are undecided about whether they should risk having surgery," she said.
Patients who reported being "unable to do work or could only do light work" were at a 2.7-5.8 fold higher probability of dying within two years than were patients who were active, the researchers also discovered. "The Page: 1 2 3 4 5 6 7 8 9 10 Related medicine news :1
. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
. Novel biopsy technique for prostate cancer3
. Novel computer model for breast cancer4
. Novel research on liver cancer 5
. Novel way to fight cancer 6
. Novel test for bowel cancer 7
. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients8
. Novel Therapy for Chronic Problem9
. Blood Sugar Kept In Control By Novel Protein10
. Novel antibiotic dressing developed for improved wound healing11
. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals